Daniel Muruve - Arch Biopartners Insider

FOIFF -- USA Stock  

null 0.33  0.00  0.00%

Co-Founder, Chief Science Officer and Member of Scientific Advisory Board
We currently do not have informatin regarding Daniel Muruve. This executive tanure with Arch Biopartners is not currenlty determined.
  Founder Since 2013      
647-428-7031  http://www.archbiopartners.com

Management Efficiency

The company has return on total asset (ROA) of (85.15) % which means that it has lost $85.15 on every $100 spent on asset. This is way below average.
The company has accumulated 246.87 K in total debt. Arch Biopartners has Current Ratio of 2.71 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

Arch Biopartners, Inc., a biotechnology company, develops solutions and technologies for medical use. Arch Biopartners (FOIFF) is traded on OTC Market in USA. It is located in Arch Biopartners, Inc.Toronto, ON MV M and employs 9 people.

Arch Biopartners Leadership Team

Conor Gunne, Director
Richard Rossman, Director
Andrew Bishop, Director, MBA
Claude Allary, Director
Daniel Muruve, Founder
Richard Muruve, CEO, MBA
Patrick Vink, Director
Adrian Haigh, Director

Stock Performance Indicators

Did you try this?

Run My Watchlist Analysis Now

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch My Watchlist Analysis

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally see Investing Opportunities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.